Ravi C Dara Shares WHO’s Phase A guidance for PBM from ISBT
Ravi C Dara, Consultant Physician Transfusion medicine at Sheikh Shakhbout Medical City, reposted from ISBT on LinkedIn:
”Better outcomes, fewer transfusions – Optimizing outcomes while reducing transfusions – WHO‘s Phase A guidance is here”
Quoting International Society of Blood Transfusion (ISBT)‘s post:
”The Patient Blood Management subgroup of the ISBT Clinical Transfusion Working Party is dedicated to spreading awareness on PBM and to help support its wider implementation.
This week, we’re shining a light on Patient Blood Management (PBM) and each day, we’ll explore a different phase of the PBM system, sharing diverse perspectives on who can benefit from it.
Patient blood management (PBM) is a new paradigm to manage and preserve an individual’s own blood in health and illness and highlighted as a patient-centered approach aimed at improving patient outcomes with reduced morbidity, mortality and length of hospital stay.
For Day 1, we’re highlighting Phase A of the WHO Implementation Guidance, focusing on the aims and initial steps involved in establishing PBM within healthcare settings.”
Stay updated with Hemostasis Today.
-
Apr 30, 2026, 18:19Deva Nanda TK: A Practical Overview of Dural Sinuses and The Venous Drainage of the Brain
-
Apr 30, 2026, 18:08Amrit Kaur Kaler: The Hidden Genetic Drivers of Thrombosis
-
Apr 30, 2026, 18:06Alejandro González Veliz: The Most Dangerous Mistake After Getting a Stent
-
Apr 30, 2026, 18:03Carmen Ruiz: First Arterial Mechanical Thrombectomy in New Zealand Using the ARTIX System
-
Apr 30, 2026, 17:52Simon Senanu: von Willebrand Disease May Be Missed Despite Normal Tests
-
Apr 30, 2026, 17:20José Antonio García Erce: Why Healthy Older Adults Should Keep Donating Blood?
-
Apr 30, 2026, 17:13Paul Logan: Decoding the Words ‘He’s on blood thinners’
-
Apr 30, 2026, 17:01Jason Andrade: A Decade-Long Quest Proves Early Ablation Halves Persistent AF Burden
-
Apr 30, 2026, 16:56Oliver Maracic: Could Co-Targeting ALK with FAK/PYK2 Help Mitigate the High VTE Burden Seen in ALK with NSCLC